Combatting Counterfeiting in the Pharmaceutical Industry

5 يوليو 2025

Eva Bishwal, Rishab Raturi and Zhen Wenzao, Global Health Unit

5 يوليو 2025

5 يوليو 2025 ・ minutes reading time

Counterfeit medicines are not only a violation of Intellectual Property (IP) rights but also pose a significant threat to health
Image: Andrey Bukreev/iStock/Getty Images Plus
Counterfeit medicines are not only a violation of Intellectual Property (IP) rights but also pose a significant threat to health; IP plays an important role in combating this issue. Through IP enforcement, patients and IP rights holders can be protected from counterfeit medicines. This article looks at the impact of the global prevalence in counterfeit medicines, its impact, and examines some of the effective strategies to address this issue.
حدث خطأ غير متوقع.
Disclaimer: The short posts and articles included in the Innovation Economics Themes Series typically report on research in progress and are circulated in a timely manner for discussion and comment. The views expressed in them are those of the authors and do not necessarily reflect those of WIPO or its Member States . ​​​​​​​

Related stories

لا توجد نتائج